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Vulval intraepithelial neoplasia (VIN) is defined histopathologically by distinctive abnormalities of cellular maturation and
differentiation. To investigate the functional properties of VIN, the expression of several proteins involved in the regulation of the cell
cycle as well as in situ DNA replication competence was analysed by immunohistochemistry. Snap-frozen vulval biopsies were graded
as normal squamous epithelium (n¼6), undifferentiated HPV positive VIN 1 (n¼3), VIN 2 (n¼8) and VIN 3 (n¼20).
Immunohistochemistry was performed using the following markers: cyclin D1 (expressed in middle/late G1), cyclin B1 (expressed in
G2/early M), phosphorylated histone H3 (expressed during mitosis) and minichromosome maintenance (Mcm) proteins 2 and 5
(expressed during the cell cycle, but not in differentiated or quiescent cells). In situ DNA replication competence was used to identify
S-phase cells. The percentage of positively stained nuclei in three representative microscopic fields was calculated per biopsy. In
normal vulva, the expression of all markers was restricted to the proliferative compartment of the basal layer of the epithelium. In
contrast in high-grade VIN, the majority of epithelial cells expressed the Mcm proteins from basal to superficial layer. The detection of
cyclins B1 and D1, phospho-histone H3 and in situ DNA replication was also found through the full thickness of these lesions but by a
lower proportion of the cells. This is consistent with these markers providing a series of ‘snapshots’ of the cell cycle status of individual
cells. The low-grade VIN showed reduced expression of the cell cycle markers in relation to the level of dysplasia. The combination of
these analyses establishes that the majority of VIN cells remain in a functional replicative or prereplicative state of the cell cycle.
Clinical application of these analyses may provide a basis for improved diagnosis of VIN.
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Vulval intraepithelial neoplasia (VIN) is a dysplastic condition of
the squamous epithelium of the vulva (Buckley et al, 1984). It is
characterised histopathologically by abnormalities of cellular
maturation and differentiation. Mitotic figures, sometimes of
abnormal or bizarre form, cellular and nuclear pleomorphism and
cells with abnormally high nuclear to cytoplasmic ratios are
observed throughout the various layers of the epithelium (Scully
et al, 1994). Lesions are classified as VIN 1, VIN 2 and VIN 3
according to the proportion of cells from the basement membrane
to the surface that are affected by these changes (Wilkinson et al,
1986). While the histopathological features associated with VIN are
well described, however, little is currently understood about the
functional properties of dysplastic vulval cells. One important
factor is the association of undifferentiated VIN with high-risk
human papillomavirus (HPV) infection (van Beurden et al, 1995).
In HPV-infected epithelium, the viral oncogenes E6 and E7 drive
the dysplasia by dysregulating the cell cycle checkpoints through
interaction with the p53 and Rb regulatory proteins (Zur Hausen,
2002).
The cell cycle is the orchestrated series of molecular events,
which coordinate the production of two daughter cells. It is
divided into four distinct phases: G1, S, G2 and M. Progression
through the successive stages of the cell cycle is accompanied by
the alternate expression and lack of expression of specific
regulatory proteins (Viallard et al, 2001). Dysregulation of the cell
cycle is known to play an important role in the oncogenic
transformation of cells (Johnson et al, 1995) and abnormal
expression patterns of cell-cycle-associated cyclin D1 and retino-
blastoma protein (Rb) have previously been documented in high-
grade VIN lesions (Rolfe et al, 2001; Zamparelli et al, 2001). Other
studies have demonstrated increased cellular proliferation in high-
grade VIN using proliferation markers Ki-67 and proliferating cell
nuclear antigen (PCNA) (van Hoeven and Kovatich, 1996; Modesitt
et al, 2000). However, the scope of these analyses is restricted to
high-grade VIN lesions and to the analysis of cell cycle proteins
normally expressed during a single phase of the cell cycle (G1).
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number of cell cycle regulatory proteins and proliferation markers
across the full spectrum of vulval dysplasia, from normal vulval
epithelium to VIN 3. The approach used has been verified in a
larger study of cell cycle kinetics in colorectal cancer (Scott et al,i n
submission). The markers used were cyclin D1, cyclin B1 and
phosphorylated histone H3, all of which are normally expressed
during distinct phases of the cell cycle (Viallard et al, 2001). Cyclin
D1 is expressed in middle/late G1 and with CDK4/6 phosphorylates
Rb, the inactivation of which is completed by cyclin E/CDK2
(Adams, 2001). Cyclin B1 is expressed in G2/early M and with
CDK1 facilitates the processes involved in mitosis (Pines and
Hunter, 1989; Ito, 2000; Taylor and Stark, 2001). Histone H3 is
phosphorylated in mitosis and is associated with mitotic chromo-
some condensation (Mahadevan et al, 1991; Goto et al, 1999). To
identify S-phase cells, in situ DNA replication competence was
used. This technique has previously been validated in a variety of
normal and neoplastic tissues, including normal squamous
epithelium of the cervix and cervical intraepithelial neoplasia
(CIN) 3 (Mills et al, 2000).
We have also compared the use of proliferation markers Mcm 2
and Mcm 5 in VIN. The Mcm proteins form an essential
prereplicative complex by binding to DNA sites at which origin
recognition complex and cdc6 proteins have sequentially bound.
Mcm proteins are only present during the cell cycle and are lost in
quiescent and differentiating cells (Ritzi et al, 1998). The use of an
antibody directed against Mcm 5 has been shown to improve the
specificity and sensitivity of cytological screening for CIN
compared with the use of conventional cervical cytology alone
(Freeman et al, 1999). Furthermore, antibodies against Mcm 2 and
Mcm 5 have consistently been shown to identify a greater number
of cycling cells than antibodies against Ki-67 or PCNA (Williams
et al, 1998; Freeman et al, 1999). Here we report the expression
pattern of Mcm proteins 2 and 5, cyclins D1 and B1, phospho-
histone H3 and in situ DNA replication competence in normal
squamous epithelium of the vulva, VIN 1, VIN 2 and VIN 3. The
Mcm proteins identify all cells actively involved in the cell cycle,
while cyclins D1 and B1, phosphohistone H3 and in situ DNA
replication detect only a fraction of cells within a particular phase
of the cell cycle.
MATERIALS AND METHODS
Patient material
In all, 37 vulval biopsies were obtained from women attending the
Vulva Clinic at St Mary’s Hospital in Manchester, UK. The Central
Manchester Local Research Ethics Committee approved the study
and all patients gave written informed consent. The tissue was
coated in OCT and snap-frozen in liquid nitrogen. Seven and
10mm sections were cut onto aminopropyltriethoxysilane (APES)-
coated slides and stained with haematoxylin and eosin (H/E) for
histopathological analysis or stored at  701C until required.
Histological grading of all vulval specimens was performed by two
independent histopathologists at St Mary’s Hospital. Biopsies were
graded as normal vulval epithelium (n¼6), VIN 1 (n¼3), VIN 2
(n¼8) and VIN 3 (n¼20). Only undifferentiated VIN associated
with high-risk HPV infection as determined by PCR was included
in this study. For HPV typing, DNA was extracted from the vulval
biopsies by incubating the samples overnight at 371C on a rotary
mixer in 500ml of guanidinium isothyocyanate (GuScn) Lysis
Buffer (12g GuScn, 635ml1M sodium citrate, 425ml 30% sarcosyl,
50ml glycogen, 250ml 0.1 M DTT, up to 25.5ml with double-distilled
H2O). Samples were spun for 1min and DNA was precipitated
from the supernatant using isopropanol. The mixture was
centrifuged at 13 000rpm for 15min, the pellet washed with 70%
ethanol for 5min and then dried at 561C for 15min before being
dissolved in 400ml of double-distilled H2O. All specimens were
positive for b-globin. HPV DNA was detected using GP5+/GP6+
consensus primers and genotyped using type specific primers for
HPV 6/11, 16, 18, 31 and 33 (Van den Brule et al, 1990).
Amplification products were resolved on 2% agarose gels and
visualised by ethidium bromide staining.
Immunohistochemical staining of specimens
Sections, 5-mm, were quick-thawed and fixed in 4% paraformalde-
hyde in phosphate-buffered saline (PBS) for 5min (Freeman et al,
1999). Endogenous peroxidase activity was quenched by incuba-
tion in 0.6% hydrogen peroxide in Tris-buffered saline (TBS) for
30min. Sections were washed in TBS and blocked with 10%
normal goat serum (DAKO, Ely, UK) and 10% bovine serum
albumin (BSA) in TBS for 90min at room temperature. The
antibody directed against cyclin D1 was preabsorbed overnight at
41C with 10% BSA in TBS. The antibodies against Mcm proteins 2
and 5, cyclin B1 and phospho-histone H3 did not require
preabsorption. Final dilutions of primary antibody were prepared
in 1% BSA and 0.1% Triton X-100 in TBS. In total, 50mlo f
antibody was added to each section and the slides were incubated
at 41C overnight in a humidified chamber. The following
concentrations were found to produce optimal staining: Mcm 2
1:25, Mcm 5 1:25, cyclin D1 1:50, cyclin B1 1:600, phosphohis-
tone H3 1:500. The primary antibody layer was omitted from a
single section of each biopsy to serve as a negative control.
The slides were washed in 0.1% Tween 20 in TBS and incubated
with biotinylated goat antimouse secondary antibody (Mcm 2 & 5
and cyclins B1 & D1) or biotinylated goat antirabbit secondary
antibody (phosphohistone H3) (both from DAKO) at 1:500 in 1%
BSA in TBS for 1h at room temperature. Streptavidin horseradish
peroxidase (HRP) (DAKO) was added for 30min, followed by the
substrate diaminobenzidine (DAB) for 10min at room tempera-
ture and the reaction stopped with running water. The slides
were counterstained with Harris’ haematoxylin, dehydrated
through graded ethanols and cleared in xylene. Coverslips were
applied with DEPEX mounting medium (Gurr, BDH, Poole, Dorset,
UK).
In situ DNA replication competence
Frozen sections, 10mm, were quick-thawed, covered with 40ml
incubation buffer (30ml SuNaSp/BSA with protease-inhibitor
cocktail and 10ml5 0 mM Dig-dUTP nucleotide mix (Boehringer
Mannheim)) and incubated at 371C for 45min in a humidified
chamber. Slides were washed in PBS and fixed with 4%
paraformaldehyde in PBS for 2min (Mills et al, 2000). Endogenous
peroxidase activity was quenched by incubation in 0.6% hydrogen
peroxide in TBS for 3min. Sections were coated with 50ml of rabbit
anti-DIG/HRP antibody at 1:50 in 1% BSA in TBS and incubated
at room temperature for 45min. The slides were washed in TBS
and DAB was used to develop the stain. The slides were
counterstained with Harris’ haematoxylin, dehydrated with
ethanol and cleared in xylene. Coverslips were applied with
DEPEX mounting medium.
Scoring of stained sections
Scoring was carried out by two independent observers (EJD and
PLS). The percentage of positively stained nuclei in three
representative high-powered microscopic fields (approximately
1000 cells) was calculated per biopsy. In addition, the distribution
of staining from basal layer to the surface layer of the epithelium
was scored. Negative control sections from each biopsy showed
negative immunostaining.
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The Spearman rank correlation coefficient (rs) was calculated for
each marker across the spectrum of vulval dysplasia (normal, VIN
1, VIN 2 and VIN 3) using the raw data values from each patient. A
value of Po0.05 was considered statistically significant.
RESULTS
Expression of cell cycle markers and in situ DNA
replication competence in normal squamous epithelium of
the vulva
In normal vulva, the expression of all cell cycle proteins and in situ
DNA replication competence was restricted to the nuclei of the
basal epithelial cells (Figure 1). Differentiating cells in the more
superficial layers of the epithelium were negative for all cell cycle
markers. Mcm proteins 2 and 5 were found in the majority of cells
in the basal epithelial layer (Table 1). In contrast, cells positively
stained for cyclins B1, D1 and phosphohistone H3 and those
exhibiting in situ DNA replication competence were found in a
subset of the basal epithelial cell layer. Less than 5% of cells in the
basal layer of the epithelium scored positive for cyclin D1 (data not
shown).
Expression of cell cycle markers and in situ DNA
replication competence in VIN 1, VIN 2 and VIN 3
Positively stained nuclei were present in the superficial epithelial
layers of all VIN lesions with antibodies against Mcm proteins 2
and 5, cyclin B1 and D1, phosphohistone H3 and by in situ DNA
replication (Figure 1). The proportion of positively stained nuclei
in the superficial epithelial layers correlated with the degree of
dysplasia. The lowest proportion was found in the VIN 1 lesions,
where positively stained nuclei were seen only in the suprabasal
epithelial layers (Table 1). A similar pattern of staining was seen
for cyclins B1 and D1, but precise quantification of the latter was
not possible because of cytoplasmic background staining.
In VIN 2 lesions, staining with all markers was seen in
superficial layers of the epithelium and by a higher proportion
of the cells overall compared with VIN 1. In VIN 3, full thickness
staining of epithelial cells from basal to superficial layers was seen
with all cell cycle markers. The majority of cells from the basement
membrane to the surface of the epithelium expressed Mcm
proteins 2 (93.4%) and 5 (94.1%). The detection of cyclins B1
and D1, phosphohistone H3 and in situ DNA replication was also
found through the full thickness of these lesions, but by a lower
proportion of cells.
There was a statistically significant correlation between the level
of dysplasia and the proportion of positively stained nuclei with
every marker investigated (Table 1). The highest Spearman rank
correlation coefficients were observed for Mcm proteins 2
(rs¼+0.91) and 5 (rs¼+0.90), Po0.001. The correlation coeffi-
cients for cyclin B1 (rs¼+0.68), phosphohistone H3 (rs¼+0.65)
and in situ DNA replication (rs¼+0.81) were also statistically
significant at the Po0.001 level.
DISCUSSION
In this study we have analysed the expression patterns of several
cell cycle regulatory proteins and proliferation markers across the
spectrum of vulval dysplasia, from normal squamous epithelium to
VIN 3. The expression of all cell cycle markers and in situ DNA
replication competence was restricted to the proliferative compart-
ment of the basal layer of normal vulval squamous epithelium. In
contrast, the majority of cells from basal to superficial layer
expressed Mcm proteins 2 and 5 in VIN 3. Cyclin D1, B1,
phosphohistone H3 and in situ DNA replication were also seen
through the full thickness of VIN 3 lesions, but in a lower
proportion of the cells. This is consistent with each marker
providing a series of ‘snapshots’ of the cell cycle status of
individual cells within the lesion. In low-grade VIN, reduced
expression of all markers was seen in relation to the level of
dysplasia, with positively stained nuclei found in the suprabasal
layers of the epithelium in VIN 1 and extending into more
superficial layers of the epithelium in VIN 2. There was a
statistically significant correlation between an increasing level of
dysplasia and a higher proportion of positively stained cells with
each of the markers tested. The best markers of increasing
dysplasia were the Mcm proteins 2 and 5, which gave correlation
coefficients of rs¼+0.91 and +0.90, respectively. Cyclin D1
expression was similar to that observed for cyclin B1, but was
more difficult to quantify precisely because of cytoplasmic
background staining.
The proportion of cells positive for Mcm proteins 2 and 5 was
similar to that previously observed in normal squamous epithe-
lium of the cervix and in low- and high-grade CIN (Williams et al,
1998). We also found that the proportion of cells demonstrating in
situ DNA replication competence was consistent with that
previously observed in the cervix (Mills et al, 2000). It should be
noted, however, that those women who had ‘normal vulval
epithelium’ by histology had presented with symptoms which
necessitated a vulval biopsy. Whether this tissue is functionally
normal is not known, but at least in histopathological terms, there
was no evidence of VIN in these sections.
This study establishes that the majority of VIN cells remain in a
functional replicative or prereplicative state of the cell cycle. All
cells actively involved in the cell cycle are detected with antibodies
against the Mcm proteins and a subset of these with each
additional cell cycle marker. As a consequence of this, immunos-
taining of VIN lesions, particularly with antibodies against the
Mcm proteins, may have a number of clinical applications. VIN 3
is a chronic condition with a significant risk of progression to
invasive vulval carcinoma (Jones, 1995). Conventional therapy,
including laser and surgical excision, is typically unsatisfactory
since lesions are multifocal and show high rates of recurrence
(Modesitt et al, 1998). Histological grading of VIN based on H/E
sections does not always accurately distinguish between VIN 2 and
VIN 3 (van Beurden et al, 1999). This may have significant clinical
implications since the decision to treat rather than continue with
conservative management may critically depend on this distinction
(van Beurden et al, 1998). The application of these approaches may
therefore provide a means of improved diagnosis of high-grade
VIN.
In cervical dysplasia, persistent infection with high-risk HPV
types potentiates the outgrowth of cervical intraepithelial neoplasia
(CIN) by the inactivation of pRb and p53 by high-risk HPV E7 and
E6, respectively. Since pRb inhibits transcription of the cyclin-
dependent kinase inhibitor p16
INK4a, p16 is markedly over-
expressed in HPV-associated CIN and cervical cancers (Klaes
et al, 2001). It is therefore possible that p16
INK4a may be a useful
marker for dysplasia in VIN. Contrary to this expectation, Chan
et al (1998) claimed that the proportion of lesions with either
undetectable p16 and/or pRb increased from benign lesions,
through increasing grade of VIN to squamous carcinoma of the
vulva. The latter study did not investigate the HPV status of the
lesions and given the pathobiological differences between HPV
positive and negative cancers (Crum, 1992), the precise relation of
VIN and p16 status is still unclear. Inactivation of p16 has
previously been shown to confer a loss of tumour-suppressor
function in high-grade gliomas (Nishikawa et al, 1995). Another
investigation of the inactivation of p16
INK4a and 14-3-3s suggested
the latter as early events in vulval squamous neoplasia (Gacso et al,
2002). Downregulation of 14-3-3s in keratinocytes allows escape
from replicative senescence and this is also accompanied by loss of
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Figure 1 Immunostaining of normal vulval epithelium and VIN 1, VIN 2 and VIN 3 with cell cycle markers (x40): (A1) normal vulval epithelium shows that Mcm 5 expression is restricted to the basal
epithelial layer; (A2) in VIN 1, 440% of cells express Mcm 5 in the basal and suprabasal epithelial layers; (A3) in VIN 2, 485% of cells express Mcm 5 and positive nuclei are detected in basal and
superficial epithelial layers; (A4) VIN 3 shows 490% of cells express Mcm 5, extending throughout the full thickness of the epithelium; (B1) in normal vulval epithelium, expression of cyclin; (B1) is
restricted to the basal epithelial layer. In VIN 1 (B2), VIN 2 (B3) and VIN 3 (B4), a greater proportion of cells express cyclin B1 compared with normal skin and positively stained nuclei are found in
progressively more superficial epithelial layers, correlating with the level of dysplasia. C1–4 and D1–4 show a similar pattern of expression of phosphohistone H3 in normal vulva (C1), VIN 1 (C2), VIN
2( C3) and VIN 3 (C4), and by in situ DNA replication in normal vulva (D1), VIN 1 (D2), VIN 2 (D3) and VIN 3 (D4).
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INK4a. It has been shown that loss of 14-3-3s, via methylation-
dependent transcriptional silencing, occurs commonly in vulval
neoplasia, and that it frequently coexists with silencing of p16 early
in the natural history of disease. A closer examination of these data
shows that most HPV-16-positive VIN 2/3 (11/12) do not have
methylated p16
INK4a, whereas in HPV-negative lesions, 8/11 VIN 3,
2/5 VIN 2 and 0/4 VIN 1 show p16 methylation. It is obvious that
there is heterogeneity in the mechanisms underlying VIN in
respect of viral and other influences on p16. The expression of
Mcm proteins is a measure of licence for the cell cycle, which is
independent of the consequences, or presence of HPV. Thus, it
seems likely that combinations of these approaches will provide a
useful synergism in the study of VIN. Mcm staining may also be
useful in directing laser capture analysis of expressed transcripts
encoding relevant viral and immunological factors in the ongoing
biological analysis of VIN (Wong et al, 2000). Further work in
long-term follow-up studies is required to establish the clinical
relevance of these analyses.
ACKNOWLEDGEMENTS
We thank Garry Ashton for cutting the frozen sections. Cancer
Research UK supported EJD and PLS; the Wigan Cancer Research
Fund Joseph Starkey Clinical Research Fellowship supported EJD.
Other authors were supported by the Medical Research Council
and Cancer Research UK.
REFERENCES
Adams PD (2001) Regulation of the retinoblastoma tumor suppressor
protein by cyclin/cdks. Biochim Biophys Acta 1471(3): M123–M133
Buckley CH, Butler EB, Fox H (1984) Vulvar intraepithelial neoplasia
and microinvasive carcinoma of the vulva. J Clin Pathol 37:
1201–1211
Chan MK, Cheung TH, Chung TK, Bao SY, Zhao CL, Nobori T, Wong YF
(1998) Expression of p16INK4 and retinoblastoma protein Rb in vulvar
lesions of Chinese women. Gynecol Oncol 68(2): 156–161
Crum CP (1992) Carcinoma of the vulva: epidemiology and pathogenesis.
Obstet Gynecol 79: 448–454
Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH,
Coleman N (1999) Minichromosome maintenance proteins as biological
markers of dysplasia and malignancy. Clin Cancer Res 5: 2121–2132
Gacso M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B,
Gusterson B, Evans DJ, Crook T (2002) Coincident inactivation of
14.3.3s and p16
INK4A is an early event in vulval squamous neoplasia.
Oncogene 21: 1876–1881
Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K,
Iwamatsu A, Okigaki T, Takahashi T, Inagaki M (1999) Identification of a
novel phosphorylation site on histone H3 coupled with mitotic
chromosome condensation. J Biol Chem 274(36): 25543–25549
Ito M (2000) Factors controlling cyclin B expression. Plant Mol Biol 43(5–
6): 677–690
Johnson DG, Richie E, Conti C (1995) The cell cycle and cancer. Cancer Bull
47: 480–485
Jones RW (1995) The natural history of vulvar intraepithelial neoplasia. Br J
Obstet Gynaecol 102: 764–766
Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U,
Dallenbach-Hellweg G, Schimdt D, von Knebel Doeberitz M (2001)
Overexpression pf p16(INK4A) as a specific marker for dyplastic
and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92:
276–284
Mahadevan LC, Willis AC, Barratt MJ (1991) Rapid histone H3
phosphorylation in response to growth factors, phorbol esters, okadaic
acid and protein synthesis inhibitors. Cell 65: 775–783
Mills AD, Coleman N, Morris LS, Laskey RA (2000) Detection of S-phase
cells in tissue sections by in situ DNA replication. Nat Cell Biol 2: 244–
245
Modesitt SC, Groben PA, Walton LA, Fowler WCJ, Van Le L (2000)
Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial
neoplasia III: correlation with clinical prognostic factors. Gynecol Oncol
76(1): 51–55
Modesitt SC, Waters AB, Walton L, Fowler WC, Van Le L (1998) Vulvar
intraepithelial neoplasia III: occult cancer and the impact of margin
status on recurrence. Obstet Gynecol 92: 962–966
Nishikawa R, Furnari FB, Lin H, Arap W, Berger MS, Cavennee WK (1995)
Loss of p16
INK4A expression is frequent in high-grade gliomas. Cancer
Res 55: 1941–1945
Pines J, Hunter T (1989) Isolation of a human cyclin cDNA: evidence for
cyclin mRNA and protein regulation in the cell cycle and interaction with
p34cdc2. Cell 58(5): 833–846
Ritzi M, Baack M, Musahl C, Romanowski P, Laskey RA, Knippers R (1998)
Human minichromosome maintenance proteins and human origin
recognition complex 2 protein on chromatin. J Biol Chem 273(38):
24543–24549
Rolfe KJ, Crow JC, Benjamin E, Reid WMN, Maclean AB, Perrett CW (2001)
Cyclin D1 and retinoblastoma protein in vulvar cancer and adjacent
lesions. Int J Gynecol Cancer 11: 381–386
Scully RE, Boniglio TA, Kurman RT, Silverberg SG, Wilkinson EJ (Eds)
(1994) Vulva. Epithelial tumors and related lesions. In Histological
Typing of Female Genital Tract Tumors, pp. 64. Berlin/Heidelberg:
Springer-Verlag
Taylor WR, Stark GR (2001) Regulation of the G2/M transition by p53.
Oncogene 20(15): 1803–1815
Table 1 Percentage of cells expressing each cell cycle marker in normal vulval epithelium and VIN 1, VIN 2 and VIN 3
Normal (n=6) VIN 1 (n=3) VIN 2 (n=8) VIN 3 (n=20) Correlation coefficient
Mcm 2 14.7 (9.9–19.4) 32.3 (19.2–52.5) 85.0 (80.5–94.1) 93.4 (82.9–97.8) rs=+0.91
Po0.001
Mcm 5 16.3 (9.7–21.7) 44.2 (33.6–61.0) 85.1 (79.6–91.7) 94.1 (84.5–98.9) rs=+0.90
Po0.001
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This table shows the mean labelling indices (percentage of stained cells) for normal vulval epithelium and VIN 1, VIN 2 and VIN 3 with each of the cell cycle markers. Similar
patterns of staining were observed for cyclins B1 and D1, but precise quantification of the latter was not possible. Ranges are given in parentheses. The proportion of positively
stained nuclei increases with the level of dysplasia with each of the markers studied. The Spearman rank correlation coefficients and level of statistical significance are shown.
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